Five Prime Therapeutics, Inc.

Report date
12/31/2020
Quarter
2020 Q4
Filed
11/25/2024
Shares
367,274
Value ($000)
6,703
Weight
0.2%
2018 Q4 - 2020 Q4 (9 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).